Results 111 to 120 of about 279,219 (179)
Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections
Mycoses, Volume 69, Issue 11, November 2026.ABSTRACT Background
Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin with once‐weekly dosing, to address some limitations of current treatments for Aspergillus infections.Neil Stone, Pablo Bachiller‐Luque, Simone Giuliano, Sumita Pai, Berta Pernas, Carolina Garcia‐Vidal, Netta Tyler, Sara Ferin, Carlo Tascini, Ana Fernández Cruz +9 morewiley +1 more sourceP083 | DOSE-ADJUSTED VENETOCLAX WITH ANTIFUNGAL PROPHYLAXIS PRESERVES EFFICACY AND LIMITS FUNGAL INFECTIONS IN ELDERLY ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER EXPERIENCE
Haematologica
Background: Acute myeloid leukemia (AML) in elderly patients with comorbidities is associated with poor outcomes. The combination of azacitidine (AZA) and the BCL-2 inhibitor venetoclax (VEN) has significantly improved clinical outcomes in this ...S. Luponio, A. Gigantiello, M. Rizzo, D. Morini, I. Conversano, L. Pezzullo, R. Fontana, R. Guariglia, L. Mettivier, I. Ferrara, M. Buonanno, M.C. Martorelli, M. Langella, M. Gorrese, D. De Novellis, V. Giudice, B. Serio, C. Selleri. +17 moredoaj Practices of Antifungal Prophylaxis Among Italian Pediatric Oncology-Hematology Centers. [PDF]
EJHaemColli M, Grasso A, Spadea M, Compagno F, Chiusaroli L, Muggeo P, Pancaldi A, Mura R, Onofrillo D, De Santis R, Mongelli B, Barone A, Rinieri S, Coccia P, Ricci E, Faraci M, D'Amico MR, Galaverna F, Gasperini P, Brescia L, Colombini A, Masetti R, Baccelli F, Cesaro S. +23 moreeuropepmc +1 more sourceFusariosis in Patients With Hematologic Malignancies in the Era of Antifungal Prophylaxis. [PDF]
Transpl Infect DisVega P, Bhattacharyya P, Lieberman JA, Kuczmarski TM, Yoke LH, So LM, Smith HZ, Lengermann R, Cohen S, Fredricks DN, Pergam SA. +10 moreeuropepmc +1 more sourceDP042 | IMPACT OF ANTIFUNGAL PROPHYLAXIS ON TRANSPLANT-RELATED MORTALITY IN MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): A PROSPECTIVE EXPERIENCE FROM A SINGLE TRANSPLANT PROGRAM
Haematologica
Background In the allogeneic HSCT, the incidence of Invasive Fungal Disease is 7-9% with high rate of mortality. Although the antifungal prophylaxis is crucial, the role of anidulafungin is unknown.A. Carobene, M. Pedata, M. Celentano, T. Ascione, C. Riccardi, S. Marotta, S. Leone, I. Migliaccio, C. Luise, U. De Martino, V. Oliva, S.M. Muggianu, M. Boccola, D. Buonanno, C. Falco, L. Altomare, A. Zuccarelli, M. Toriello, R. Penta, and A. Picardi +19 moredoaj Antifungal Prophylaxis in Solid Organ Transplant Recipients
Solid organ transplantation (SOT) is a treatment method that improves quality of life and survival of patients with end-stage organ failure. Immunosuppressive treatments given to these patients may predispose to the development of invasive fungal ...Ergin, C, Metin, DY, Çetin, CB, Pullukçu, H, Avci, M, Oguz, VA, Kutlu, M, Baysan, BÖ, Yapar, N, Çavus, SA, Ertugrul, B, Kaya, O, Tasbakan, MI, Mermut, G, Turhan, Ö, Kutsoylu, OE, Öztürk, B, Kutlu, SS, Senol, S +18 morecore Liposomal amphotericin B as an antifungal prophylaxis in bilateral lung transplantation: a safety analysis. [PDF]
BMC Pharmacol ToxicolBoscolo A, Sella N, Congedi S, Paiusco I, Pistollato E, Zanaga A, Chiapperini F, Zarantonello F, Mormando G, Pagliarini G, De Cassai A, Pettenuzzo T, Dell'Amore A, Navalesi P. +13 moreeuropepmc +1 more sourceTreatment and outcome of chronic disseminated candidiasis in the era of antifungal prophylaxis: a retrospective multicentre cohort of 111 patients. [PDF]
EClinicalMedicineReinhold I, Ramirez-Sanchez IC, Chen PY, Chen YC, Dhariwal A, Lambourne J, Agrawal S, Bastida M, Gudiol C, Alfandari S, Di Pilla A, Khostelidi S, Aguilar-Zapata D, Barac A, Cipriano A, Ehrlich S, Grothe J, Illarramendi J, Jennrich S, Khedr R, Leotta D, Méndez GA, Nacov JA, Nagao M, Saydam G, Schwartz S, Steinmann J, Arn K, Enoch DA, Föhring D, Joean O, Koehler P, Krause R, Maertens J, Marchesi F, Onyeaghala C, Stone N, Vanbiervliet Y, Wolfensberger N, Haensel L, Hurraß J, Panse J, Sal E, Stemler J, Bové DS, Sprute R, Minero MV, Vena A, Pagano L, Cornely OA, Seidel D, FungiScope® Working Group of the European Confederation of Medical Mycology (ECMM) and the International Society for Human and Animal Mycology (ISHAM);, Fungal Infections Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG) and the ESCMID Study Group for Infections in Compromised Hosts (ESGICH). +52 moreeuropepmc +1 more source